Informations générales (source: ClinicalTrials.gov)
Evaluation of the Multidimensional Impact of Therapeutic Education Workshops for COPD Patients, Cared for by the Maison de Prévention de la Santé et d'Accompagnement Thérapeutique, in the North-West Val d'Oise Area (MPSAT-ETP)
Interventional
N/A
Hôpital NOVO (Voir sur ClinicalTrials)
mars 2024
septembre 2025
23 août 2024
The aim of this study is to assess the impact of the Patient Therapeutic Education (PTE)
workshops offered by the Maison de Prévention de la Santé et d'Accompagnement
Thérapeutique (MPSAT) on the follow-up and feelings of the COPD patients who take part.
These workshops are organised outside the hospital environment and supervised by hospital
and town professionals in the NOVO zone.
Etablissements
Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
HOPITAL NOVO | TAUVERON | 04/07/2024 11:05:02 | Contacter |
Critères
Tous
Inclusion Criteria :
- Patient aged 18 or over
- Patient living in the NOVO hospital area and the border towns of Yvelines, Oise and
Eure
- Patient with a diagnosis of COPD confirmed by EFR, whatever the stage
For PTE group :
- Patient who has already attended at least 3 PTE workshops offered by MPSAT
For Control group :
- Patient on waiting list for PTE workshops offered by MPSAT
Exclusion Criteria :
- Patient refusing to take part in study
- Patient under legal protection
- Patient with cognitive disorders, unstable clinical conditions, language barriers or
other conditions that prevent them from understanding the study and answering the
questionnaires
- Patient aged 18 or over
- Patient living in the NOVO hospital area and the border towns of Yvelines, Oise and
Eure
- Patient with a diagnosis of COPD confirmed by EFR, whatever the stage
For PTE group :
- Patient who has already attended at least 3 PTE workshops offered by MPSAT
For Control group :
- Patient on waiting list for PTE workshops offered by MPSAT
Exclusion Criteria :
- Patient refusing to take part in study
- Patient under legal protection
- Patient with cognitive disorders, unstable clinical conditions, language barriers or
other conditions that prevent them from understanding the study and answering the
questionnaires